VERGELLI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.877
EU - Europa 4.239
AS - Asia 1.968
SA - Sud America 206
AF - Africa 42
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.366
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.847
PL - Polonia 1.876
RU - Federazione Russa 1.098
SG - Singapore 554
HK - Hong Kong 544
CN - Cina 421
IT - Italia 286
SE - Svezia 244
IE - Irlanda 242
KR - Corea 183
BR - Brasile 170
DE - Germania 119
GB - Regno Unito 105
UA - Ucraina 81
VN - Vietnam 81
FI - Finlandia 77
IN - India 52
ID - Indonesia 37
AU - Australia 32
FR - Francia 32
JO - Giordania 26
BE - Belgio 24
NL - Olanda 20
CA - Canada 17
ES - Italia 15
CI - Costa d'Avorio 14
TR - Turchia 14
AR - Argentina 11
JP - Giappone 11
MX - Messico 10
ZA - Sudafrica 8
EC - Ecuador 7
EG - Egitto 7
IQ - Iraq 7
BD - Bangladesh 5
SA - Arabia Saudita 5
CH - Svizzera 4
PE - Perù 4
PY - Paraguay 4
SC - Seychelles 4
TN - Tunisia 4
KZ - Kazakistan 3
LV - Lettonia 3
PK - Pakistan 3
RO - Romania 3
UZ - Uzbekistan 3
VE - Venezuela 3
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
DK - Danimarca 2
IR - Iran 2
PH - Filippine 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SO - Somalia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 11.366
Salva come PNG Salva come JPEG
Città #
Warsaw 1.873
Santa Clara 1.207
Hong Kong 490
Fairfield 445
Ashburn 403
Singapore 349
Chandler 289
Dublin 241
Seattle 220
Seoul 180
Cambridge 178
Woodbridge 177
Houston 157
Ann Arbor 144
Beijing 138
Wilmington 134
Jacksonville 128
Florence 112
Buffalo 106
Hefei 95
Altamura 88
Lawrence 83
Los Angeles 77
Princeton 71
Dallas 59
Boston 41
Boardman 40
Mumbai 39
Moscow 38
Medford 37
Munich 37
Jakarta 34
Melbourne 31
Dong Ket 27
Shanghai 27
New York 26
San Diego 26
Brussels 23
London 23
The Dalles 21
Paris 20
Council Bluffs 17
Clifton 16
Ho Chi Minh City 16
Kent 16
Abidjan 14
Barcelona 13
Turku 13
Hillsboro 12
Phoenix 12
Redondo Beach 12
Helsinki 11
Norwalk 10
São Paulo 10
Tokyo 10
West Jordan 10
Chicago 9
Izmir 9
Yubileyny 9
Brooklyn 8
Groningen 8
Hanoi 8
Lappeenranta 8
Milan 8
Belo Horizonte 7
Falls Church 7
Frankfurt Am Main 7
Toronto 7
Curitiba 6
Frankfurt am Main 6
Fuzhou 6
Gavirate 5
San Jose 5
Teresópolis 5
Andover 4
Cairo 4
Guayaquil 4
Johannesburg 4
Montreal 4
Napoli 4
North Charleston 4
Philadelphia 4
Rio de Janeiro 4
Riyadh 4
Rome 4
San Francisco 4
Secaucus 4
Tampa 4
Tappahannock 4
Amsterdam 3
Auburn Hills 3
Baghdad 3
Bern 3
Biên Hòa 3
Denver 3
Dhaka 3
Elk Grove Village 3
Esslingen am Neckar 3
Fortaleza 3
Guangzhou 3
Totale 8.347
Salva come PNG Salva come JPEG
Nome #
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 357
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists 313
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors 303
Isoxazolo-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors 301
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists. 275
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 264
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase 261
Synthesis and evaluation as PDE4 inhibitors of pyrimidine-2,4-dione derivatives 259
Synthesis and evaluation as antitubercular agents of 5-arylethenyl and 5-(hetero)aryl-3-isoxazolecarboxylate 256
Synthesis and pharmacological evaluation of new pyridazin-based thioderivatives as formyl peptide receptor (FPR) agonists 256
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 252
Synthesis, enantioresolution and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. 233
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. 231
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 227
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase 223
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 222
New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4-(3H)-ones fluoroderivatives as human A1 adenosine receptor ligands 221
Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors 208
Synthesis of five and six-membered N-phenylacetamido substituted heterocycles as formyl peptide receptor agonists 195
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. 187
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors 186
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold 184
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 183
Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors 177
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase 175
4-Amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action 172
Cinnoline derivatives as human neutrophil elastase inhibitors 170
Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis. 169
SELECTIVE ACAT INHIBITORS AS PROMISING ANTIHYPERLIPIDEMIC, ANTIATHEROSCLEROTIC AND ANTI-ALZHEIMER DRUGS 164
ISOXAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS LEISHMANIA MEXICANA PDE INHIBITORS 161
4-AMINO-3(2H)-PYRIDAZINONES BEARING ARYLPIPERAZINYLALKYL GROUPS AND RELATED COMPOUNDS: SYNTHESIS AND ANTINOCICEPTIVE ACTIVITY 161
NOVEL 3-ARYLAMINO- AND 3-CYCLOALKYLAMINO-5,6-DIPHENYLPYRIDAZINES ACTIVE AS ACAT INHIBITORS 158
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action 156
6-Methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors. 151
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 150
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: synthesis and evaluation of their phosphodiesterase 4 inhibitory activity 149
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 147
4-amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: synthesis, SARs, and preliminary studies on the mechanism of action 145
AIRWAY RELAXANT AND ANTI-INFLAMMATORY PROPERTIES OF A PDE 4 INHIBITOR WITH LOW AFFINITY FOR THE HIGH-AFFINITY ROLIPRAM BINDING SITE 143
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis 139
New pyrazolo[1',5':1,6]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors 138
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists 137
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors 133
'Proximity frequencies' a new parameter to evaluate the profile of GABAAR modulators 131
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis 130
New 3,6-disubstituted pyrazolo[1,5-a]quinazolines as ligands to GABAA receptor subtype 129
PDE5 Inhibitors and their applications 122
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. 122
Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic study 120
4-amino-5-vinyl-3(2H)-pyridazinones and related compounds: synthesis and evaluation of antinociceptive activity 119
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A1 adenosine receptor ligands 118
SYNTHESIS AND EVALUATION OF SOME PYRAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS PDE5 INHIBITORS POTENTIALLY USEFUL AS PERIPHERAL VASODILATOR 115
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABAA Receptor Subtype 112
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors 111
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity 103
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 102
Alpha-2-agonist as analgesic agents 102
New quinoline-based PDE4 inhibitors through GSK-256066 fragment-based elaboration 101
Preparation of pyridazin-3(2H)-ones and their use as PDE4 inhibitors 101
preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 99
Synthesis and evaluation of novel pyrrolo[2,3-d] and thieno[2,3-d]pyridazinones as in vitro antiproliferative agents 99
Preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 96
GABAA receptor modulators with a pyrazolo[1,5-a]quinazoline core: synthesis, molecular modelling studies and electrophysiological assay 94
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors 92
Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity agents as potential agents for treatment of erectile dysfunction 92
NEW SYNTHESIS OF DIFFERENTLY FUSED PYRIDAZINONQUINOLINES 92
Molecular manipulation of the 1,5,6,7-tetrahydro-4 H -indazol-4-one scaffold to obtain new human neutrophil elastase (HNE) inhibitors 90
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets 76
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis 74
Pyridazin-3(2H)-one derivatives as novel PDE IV inhibitors 71
Polynitrogen Bicyclic and Tricyclic Compounds as PDE4 Inhibitors 50
Totale 11.555
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.383
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021698 0 0 0 0 0 123 70 82 126 178 46 73
2021/2022508 16 34 40 17 17 32 17 36 20 39 121 119
2022/20231.232 123 271 47 102 99 207 153 65 99 5 42 19
2023/2024405 12 48 81 22 22 54 12 96 8 27 16 7
2024/20253.470 123 324 173 470 1.000 467 63 161 395 76 94 124
2025/20261.797 365 514 299 192 399 28 0 0 0 0 0 0
Totale 11.555